Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Intranasal Dexmedetomidine-esketamine Combination on Neurocognitive Recovery in Older Patients After Noncardiac Surgery
NCT07914803Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Nov 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in Postoperative neurocognitive disorder (PND), sponsored by Peking University First Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
Postoperative neurocognitive disorder (PND)
Beyond the preview
Go deeper on NCT07914803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914803.